JP2024540319A5 - - Google Patents
Info
- Publication number
- JP2024540319A5 JP2024540319A5 JP2024526661A JP2024526661A JP2024540319A5 JP 2024540319 A5 JP2024540319 A5 JP 2024540319A5 JP 2024526661 A JP2024526661 A JP 2024526661A JP 2024526661 A JP2024526661 A JP 2024526661A JP 2024540319 A5 JP2024540319 A5 JP 2024540319A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cftr
- betamethasone
- hyaluronic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306554 | 2021-11-05 | ||
| EP21306554.3 | 2021-11-05 | ||
| PCT/EP2022/080807 WO2023079072A1 (en) | 2021-11-05 | 2022-11-04 | Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540319A JP2024540319A (ja) | 2024-10-31 |
| JP2024540319A5 true JP2024540319A5 (https=) | 2025-09-16 |
Family
ID=78770564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526661A Pending JP2024540319A (ja) | 2021-11-05 | 2022-11-04 | 肺粘膜炎症の処置のための低分子量ヒアルロン酸の使用 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4426317A1 (https=) |
| JP (1) | JP2024540319A (https=) |
| WO (1) | WO2023079072A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12285541B2 (en) * | 2023-01-26 | 2025-04-29 | Insignia Pharmaceuticals, Llc | Pharmaceutical compositions for treating osteoarthritis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7060691B2 (en) * | 2002-10-10 | 2006-06-13 | Giuseppe Petrigni | Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases |
| FR2847818B1 (fr) | 2002-11-28 | 2008-04-04 | Agro Ind Rech S Et Dev Ard | Composition pharmaceutique a base d'acide hyaluronique |
| FR2919185B1 (fr) | 2007-07-23 | 2010-09-10 | Ard Sa | Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses |
| CN116515924A (zh) * | 2014-04-16 | 2023-08-01 | 青岛惠诺德生物科技有限公司 | 一种生物活性透明质酸片段、其生产方法、应用、制剂及含有该制剂的物品 |
| US20230172950A1 (en) * | 2020-04-29 | 2023-06-08 | Avm Biotechnology, Llc | Glucocorticoid Receptor (GR) Modulators for Treating a SARS-COV-2 Virus |
| WO2022236585A1 (zh) * | 2021-05-10 | 2022-11-17 | 傅毓秀 | 玻尿酸用于制备治疗肺纤维化药剂的用途 |
-
2022
- 2022-11-04 JP JP2024526661A patent/JP2024540319A/ja active Pending
- 2022-11-04 EP EP22813961.4A patent/EP4426317A1/en active Pending
- 2022-11-04 WO PCT/EP2022/080807 patent/WO2023079072A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Edsbäcker et al. | Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids? | |
| US5192528A (en) | Corticosteroid inhalation treatment method | |
| JP2024540319A5 (https=) | ||
| JP2023530166A5 (https=) | ||
| Toogood | High-dose inhaled steroid therapy for asthma | |
| JP2017197569A5 (https=) | ||
| Saha et al. | Growth of asthmatic children is slower during than before treatment with inhaled glucocorticoids | |
| EP2923702A1 (en) | Composition of cyclodextrin with budesonide derivatives for treatment and prevention of pulmonary inflammatory disease | |
| JP2022507103A5 (https=) | ||
| Vance et al. | Effects of particle size of inhaled corticosteroid on the voice | |
| Lipworth | Targets for inhaled treatment | |
| Hatton et al. | A comparison of ‘abruptly stopping’with ‘tailing off’oral corticosteroids in acute asthma | |
| EDiGER et al. | Clinical effectiveness of nebulised budesonide in the treatment of acute asthma attacks | |
| JP2020536859A5 (https=) | ||
| Szefler | A review of budesonide inhalation suspension in the treatment of pediatric asthma | |
| Ververeli et al. | Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma | |
| EP4426317A1 (en) | Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation | |
| EP1073441A1 (en) | Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease) | |
| Bateman et al. | Randomized comparison of ciclesonide 160 and 640 μg/day in severe asthma | |
| Lipworth et al. | High-dose inhaled steroids in asthmatic children | |
| König | Evidence for benefits of early intervention with non‐steroidal drugs in asthma | |
| Smith et al. | A controlled trial of beclomethasone dipropionate for asthma | |
| JP2024513388A5 (https=) | ||
| Kondekar et al. | To compare the efficacy of oral Deflazacort, oral prednisolone and inhaled Budesonide in the treatment of salbutamol refractory acute asthma in children | |
| Escribano et al. | Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial |